All Insiders Activity for Actinium Pharmaceuticals Inc. (Delaware) (ATNM)

$ 0.428 R     -0.1383 (-24.42%) Volume: 53.23m 4:00 PM EDT 6-Aug-2020
After Hours:  $ 0.4265   -0.0015 (-0.35%) Volume: 661.4k 7:59 PM EDT 6-Aug-2020
Name: Transaction:
Date Name: Shares Transaction Value
07/12/19 Mark S. Berger,
Chief Medical Officer
400,000 Acqusition at $0.232 per share. $92,800
03/05/19 Mark S. Berger,
Chief Medical Officer
3,500 Option Exercise at $0.60 per share. $2,100
07/13/18 Mark S. Berger,
Chief Medical Officer
250,000 Acqusition at $0.783 per share. $195,750
03/06/18 Mark S. Berger,
Chief Medical Officer
14,000 Other at $0.50 per share. $7,000
06/15/17 Mark S. Berger,
Chief Medical Officer
5,000 Buy at $1.11 per share. $5,550
View Section 16 Filings (Forms 3,4,5) for ATNM Insider Summary For ATNM